ADAPTIMMUNE THERAPEUTICS PLC Cash and Restricted Cash
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Cash and Restricted Cash of $27.78 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-08-13
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27.78M.
- 2025-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $43.00M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $93.21M.
- 2024-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $119.42M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-06-30 | $27.78M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $43.00M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $93.21M 10-Q · filed 2025-08-13 |
| 2024-09-30 | $119.42M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $214.68M 10-Q · filed 2025-08-13 |
| 2024-03-31 | $143.53M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $147.02M 10-Q · filed 2025-08-13 |
| 2023-09-30 | $93.07M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $80.20M 10-Q · filed 2024-08-12 |
| 2023-03-31 | $121.44M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $109.60M 10-K · filed 2025-03-24 |
| 2022-09-30 | $80.71M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $99.52M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $91.25M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $151.67M 10-K · filed 2025-03-24 |
| 2021-09-30 | $44.63M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $55.09M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $37.04M 10-Q · filed 2022-05-09 |
| 2020-12-31 | $61.48M 10-K · filed 2024-03-06 |
| 2020-09-30 | $82.91M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $126.68M 10-Q · filed 2021-08-09 |
| 2020-03-31 | $90.76M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $54.91M 10-K · filed 2023-03-06 |
| 2019-09-30 | $43.73M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $38.98M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $54.39M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $72.48M 10-K · filed 2022-03-14 |
| 2018-09-30 | $157.24M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $46.51M 10-Q · filed 2019-08-01 |
| 2018-03-31 | $57.73M 10-Q · filed 2019-05-06 |
| 2017-12-31 | $88.30M 10-K · filed 2021-02-25 |
| 2017-09-30 | $149.56M 10-Q · filed 2018-11-06 |
| 2017-06-30 | $126.15M 10-Q · filed 2018-08-02 |
| 2017-03-31 | $174.61M 10-Q · filed 2018-05-09 |
| 2016-12-31 | $162.80M 10-K · filed 2019-02-27 |
| 2016-09-30 | $144.59M 10-Q · filed 2017-11-02 |
| 2015-12-31 | $198.77M 10-K · filed 2019-02-27 |
| 2015-06-30 | $229.05M 10-K · filed 2018-03-15 |
| 2014-06-30 | $51.18M 10-K · filed 2018-03-15 |